# Study of Intraparenchymal Therapy With Irinotecan Drug Eluting Beads as Adjunct to Recurrent Surgically Resectable High Grade Glioma

> **NCT02481960** · PHASE1,PHASE2 · TERMINATED · sponsor: **Boston Scientific Corporation** · enrollment: 5 (actual)

## Conditions studied

- Glioma

## Interventions

- **PROCEDURE:** CM-BC2 Irinotecan drug-eluting bead

## Key facts

- **NCT ID:** NCT02481960
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-02-21
- **Primary completion:** 2015-12-18
- **Final completion:** 2015-12-18
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** The decision to terminate the trial was based on the slow rate of recruitment across the programme of studies\]
- **Last updated:** 2021-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02481960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02481960, "Study of Intraparenchymal Therapy With Irinotecan Drug Eluting Beads as Adjunct to Recurrent Surgically Resectable High Grade Glioma". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT02481960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*